Inhibikase Therapeutics (IKT) Stock Chart & Stock Price History → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free IKT Stock Alerts $1.40 +0.14 (+11.11%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Inhibikase Therapeutics Stock Price Performance5 Day Performance+0.72%1 Month Performance-34.27%3 Month Performance-47.76%6 Month Performance+40.00%Year-To-Date Performance+10.24%1 Year Performance-61.86% Receive IKT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 IKT Stock Chart for Thursday, May, 9, 2024 IKT Chart by TradingView Inhibikase Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$1.26$1.40+11.11%$1.55$1.3134,551 shs$9.07 million05/07/2024$1.29$1.26-2.33%$1.30$1.2030,515 shs$8.17 million05/06/2024$1.39$1.29-7.19%$1.45$1.2971,291 shs$8.36 million05/03/2024$1.34$1.39+3.73%$1.51$1.3346,964 shs$9.01 million05/02/2024$1.35$1.34-0.74%$1.40$1.2969,386 shs$8.68 million05/01/2024$1.47$1.35-8.16%$1.45$1.3594,289 shs$8.74 million Get the Latest News and Ratings for IKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$1.59$1.47-7.55%$1.60$1.4355,165 shs$9.53 million04/29/2024$1.71$1.59-7.02%$1.76$1.5940,155 shs$10.30 million04/26/2024$1.86$1.71-8.06%$1.82$1.6798,983 shs$11.08 million04/25/2024$1.87$1.86-0.53%$1.90$1.7121,378 shs$12.05 million04/24/2024$1.58$1.87+18.35%$1.87$1.5462,107 shs$12.12 million04/23/2024$1.37$1.58+15.33%$1.60$1.4479,090 shs$10.24 million04/22/2024$2.04$1.37-32.84%$1.96$1.29367,713 shs$8.88 million04/19/2024$2.10$2.04-2.86%$2.13$2.0252,727 shs$13.22 million04/18/2024$2.13$2.10-1.41%$2.15$2.0427,598 shs$13.61 million04/17/2024$2.16$2.13-1.39%$2.20$2.1137,008 shs$13.80 million04/16/2024$2.20$2.16-1.59%$2.30$2.1312,949 shs$14.00 million04/15/2024$2.19$2.20+0.23%$2.25$2.1427,860 shs$14.22 million04/12/2024$2.25$2.19-2.67%$2.22$2.1531,317 shs$14.19 million04/11/2024$2.19$2.25+2.74%$2.25$2.1524,619 shs$14.58 million04/10/2024$2.13$2.19+2.82%$2.20$2.0928,732 shs$14.19 million04/09/2024$2.21$2.13-3.62%$2.20$2.0524,120 shs$13.80 million04/08/2024$2.20$2.21+0.45%$2.29$2.1534,726 shs$14.32 million04/05/2024$2.20$2.20$2.27$2.1542,009 shs$14.26 million04/04/2024$2.15$2.20+2.33%$2.27$2.1550,804 shs$14.26 million04/03/2024$2.15$2.15$2.28$2.0926,489 shs$13.93 million04/02/2024$2.16$2.15-0.46%$2.29$2.1246,468 shs$13.93 million04/01/2024$2.16$2.16$2.28$2.0167,763 shs$14.00 million03/29/2024$2.16$2.16$2.44$2.0897,891 shs$13.33 million03/28/2024$2.30$2.16-6.09%$2.44$2.0897,781 shs$13.33 million03/27/2024$2.29$2.30+0.44%$2.32$2.2514,636 shs$14.19 million03/26/2024$2.21$2.29+3.62%$2.39$2.2140,390 shs$14.13 million03/25/2024$2.23$2.21-0.90%$2.35$2.2030,251 shs$13.64 million03/22/2024$2.21$2.23+0.90%$2.25$2.1418,974 shs$13.76 million03/21/2024$2.05$2.21+7.80%$2.30$1.9250,973 shs$13.64 million03/20/2024$1.93$2.05+6.22%$2.10$1.9171,762 shs$12.65 million03/19/2024$2.01$1.93-3.98%$2.02$1.8175,747 shs$11.91 million03/18/2024$2.11$2.01-4.74%$2.17$1.9689,529 shs$12.40 million03/15/2024$2.13$2.11-0.94%$2.21$2.0536,505 shs$13.02 million03/14/2024$2.23$2.13-4.48%$2.30$2.1147,591 shs$13.15 millionThe A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself.03/13/2024$2.27$2.23-1.76%$2.35$2.2129,315 shs$13.77 million03/12/2024$2.43$2.27-6.58%$2.42$2.1147,513 shs$14.01 million03/11/2024$2.47$2.43-1.62%$2.46$2.2937,130 shs$14.99 million03/08/2024$2.42$2.47+2.07%$2.49$2.3831,667 shs$15.24 million03/07/2024$2.41$2.42+0.41%$2.49$2.2944,393 shs$14.93 million03/06/2024$2.38$2.41+1.26%$2.41$2.2355,099 shs$14.87 million03/05/2024$2.25$2.38+5.78%$2.44$2.1973,944 shs$14.69 million03/04/2024$2.15$2.25+4.65%$2.25$2.0950,020 shs$13.89 million03/01/2024$2.16$2.15-0.46%$2.22$2.0779,263 shs$13.27 million02/29/2024$2.22$2.16-2.70%$2.35$2.1462,871 shs$13.33 million02/28/2024$2.26$2.22-1.77%$2.31$2.1167,652 shs$13.70 million02/27/2024$2.22$2.26+1.80%$2.34$2.1452,241 shs$13.94 million02/26/2024$2.14$2.22+3.74%$2.22$2.0372,519 shs$13.70 million02/23/2024$2.18$2.14-1.83%$2.23$2.0458,096 shs$13.20 million02/22/2024$2.22$2.18-1.80%$2.40$2.02138,394 shs$13.45 million02/21/2024$2.28$2.22-2.63%$2.38$2.1252,071 shs$13.70 million02/20/2024$2.36$2.28-3.39%$2.41$2.1852,152 shs$14.07 million02/19/2024$2.36$2.36$2.45$2.12136,000 shs$14.56 million02/16/2024$2.37$2.36-0.42%$2.45$2.12135,957 shs$14.56 million02/15/2024$2.54$2.37-6.69%$2.60$2.37155,561 shs$14.63 million02/14/2024$2.47$2.54+2.83%$2.60$2.40160,574 shs$15.68 million02/13/2024$2.56$2.47-3.52%$2.60$2.42176,373 shs$15.24 million02/12/2024$2.68$2.56-4.48%$2.76$2.54105,633 shs$15.80 million02/09/2024$2.75$2.68-2.55%$2.81$2.60174,797 shs$16.54 million02/08/2024$2.72$2.75+1.10%$2.98$2.75394,683 shs$16.97 million Related Companies: PHXM Stock Price Chart ENVB Stock Price Chart WINT Stock Price Chart EIGR Stock Price Chart EVAX Stock Price Chart LIAN Stock Price Chart BRTX Stock Price Chart BFRI Stock Price Chart ATHE Stock Price Chart ERNA Stock Price Chart Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:IKT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchObama’s Forever Term [exposed]Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibikase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.